However, two out of five CD34+ CML primary cells showed some degree of P-crkl expression at 72h post-IM treatment (Fig 4b), suggesting that these two samples (CML-2 and CML-4) are resistant to IM treatment. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.